Language: BG BG
← Back to results
Active (not recruiting) Phase 4 NCT05947760

Magnesium as an Adjuvant Agent for Postoperative Pain

Phase 4 – monitoring after market approval
Conditions: Pain, Postoperative

Sponsor: University Hospitals Cleveland Medical Center

trial.available_in: БГ
Overview
Participants are being asked to participate in this research study because they have elected to undergo periacetabular osteotomy (PAO). This research study is looking at if using IV magnesium during surgery can help to reduce pain after surgery.
Who can participate
Inclusion Criteria: * Patients undergoing periacetabular osteotomy with or without adjuvant hip arthroscopy Exclusion Criteria: * illiterate or non-English speaking patients * patients with 2nd or 3rd degree AV block * patients with severe renal insufficiency * patients with heart failure * patients with bradycardia
Interventions
IV Magnesium Sulfate
DRUG
Locations 1
United States (1)
University Hospitals
Cleveland , Ohio
Technical details
Status
Active (not recruiting)
Phase
Phase 4
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
14 Years
Maximum age
89 Years
Healthy volunteers
No
Start date
10.03.2025
Completion date
31.08.2026
Registry ID
NCT05947760
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.